Fund Performance
Lumpsum
SIP
20.42
as on 03 Oct 20223 Years
Investment of ₹ 10,000 in this fund 3 Years back would be ₹ 17,469 today.
NAV Performance
Fund Information
-
₹ 17.400
as on 03 Oct 2022 -
Regular - Growth
-
-
-
₹ 1,000
-
₹ 545 Cr.
as on 31 Dec 2021 -
2.51%
-
10 Jul 2019
-
S&P BSE Healthcare TRI
-
Aditya Birla Sun Life Mutual Fund
Show All Funds -
Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges.
Highlights of this fund
Aditya Birla Sun Life Pharma & Healthcare Fund is an Open-ended Equity Fund. The fund belongs to Sectoral/Thematic category, where the investment is done in predominantly in stocks that are listed on Stock Exchanges like the Bombay Stock Exchange (BSE) or the National Stock Exchange (NSE) in India as well as Global stock exchanges like the Dow Jones, London Stock Exchange or LSE etc. This fund was started on 10 Jul 2019. This fund is offered by one of the top AMC (Assets Management Company) Aditya Birla Sun Life Mutual Fund. You can also view here all other Equity funds offered by Aditya Birla Sun Life Mutual Fund.
Latest NAV of the fund is ₹ 17.400 as on 03 Oct 2022.
This fund has 3 years of track record. Since 31 Oct 2021 expense ratio of this fund is 2.51%. Ideally you shoulds compare this fund with the benchmark S&P BSE Healthcare TRI.
You can invest in this fund in SIP with the minimum investment of ₹ 500. Lumpsum invest is offered with minimum investment of ₹ 1,000.
Fund Objective
The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
List of Fund Managers of Aditya Birla Sun Life Pharma & Healthcare Fund
-
About Dhaval Shah
Dhaval Shah is a Fund Manager and Senior Analyst with Aditya Birla Sun Life AMC Limited (ABSLAMC). He comes with an overall experience of 14 years in the Indian equity markets, and has been a part of ABSLAMC since 2015. Prior to ABSLAMC, Dhaval worked with Reliance Capital Asset Management Ltd., Morgan Stanley Investment Management and Edelweiss Securities Ltd. Dhaval is an MBA in Finance from Mumbai University and also holds a CFA Charter.
Riskometer : Risk associated with this fund
Investors understand that their principal will be at High Risk
Fund Return Comparison
| Fund Name | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | 5 Years | 10 Years | 1 Year | 2 Years | 3 Years | 5 Years | 10 Years |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Category Best | 4.31% | 18.05% | 14.28% | 21.28% | 55.73% | 37.77% | 25.50% | 20.36% | 25.58% | 33.56% | 44.95% | 30.93% | 20.90% |
| Category Average | -2.28% | 10.51% | 0.02% | -0.24% | 26.71% | 18.59% | 11.12% | 13.18% | 2.53% | 12.39% | 19.36% | 14.94% | 13.29% |
| Aditya Birla Sun Life Pharma & Healthcare Fund | 3.26%₹ 10,326 | 6.29%₹ 10,629 | -4.55%₹ 9,544 | -12.08%₹ 8,792 | -5.21%₹ 11,660 | 6.73%₹ 11,394 | -0.21%₹ 23,947 | 20.42%₹ 17,469 | 10.31%₹ 42,024 | - | - | - | - |
| Quant Infrastructure Fund | -3.49%₹ 9,650 | 15.72%₹ 11,572 | 1.89%₹ 10,189 | 13.48%₹ 11,347 | 10.52%₹ 12,672 | 55.73%₹ 24,309 | 33.56%₹ 32,877 | 37.77%₹ 26,170 | 44.95%₹ 67,127 | 20.96%₹ 25,912 | 30.93%₹ 1,28,256 | 15.13%₹ 40,957 | 20.74%₹ 3,58,533 |
| Quant Consumption Fund | -1.33%₹ 9,867 | 14.63%₹ 11,463 | 0.68%₹ 10,067 | 3.23%₹ 10,322 | 7.99%₹ 12,512 | 39.18%₹ 19,405 | 23.49%₹ 30,108 | 35.67%₹ 24,990 | 35.97%₹ 59,863 | 17.87%₹ 22,758 | 26.39%₹ 1,15,150 | 17.41%₹ 49,811 | 20.90%₹ 3,61,554 |
| Mirae Asset Healthcare Fund | 3.21%₹ 10,321 | 8.96%₹ 10,896 | -1.31%₹ 9,868 | -7.37%₹ 9,263 | -0.33%₹ 11,979 | 12.10%₹ 12,574 | 5.25%₹ 25,322 | 30.13%₹ 22,053 | 18.11%₹ 47,008 | - | - | - | - |
| ICICI Prudential Technology Fund | -2.89%₹ 9,711 | -2.09%₹ 9,791 | -22.16%₹ 7,784 | -18.88%₹ 8,112 | -26.51%₹ 10,200 | 24.74%₹ 15,577 | 1.54%₹ 24,386 | 29.42%₹ 21,694 | 24.08%₹ 51,074 | 25.36%₹ 30,972 | 23.45%₹ 1,07,304 | 20.36%₹ 63,881 | 19.92%₹ 3,42,965 |
| DSP Healthcare Fund | 4.27%₹ 10,427 | 8.77%₹ 10,876 | -3.65%₹ 9,634 | -9.67%₹ 9,033 | -3.28%₹ 11,786 | 9.21%₹ 11,932 | 1.88%₹ 24,471 | 29.31%₹ 21,638 | 15.73%₹ 45,451 | - | - | - | - |
Portfolio Holdings
Top Sector Holdings of Aditya Birla Sun Life Pharma & Healthcare Fund
| Name of Sector | Holding Percentage | Holding Values in Crore |
|---|---|---|
| Pharmaceuticals | 77.85% | ₹ 437.42 Cr. |
| Hospital | 11.94% | ₹ 67.03 Cr. |
| Healthcare service providers | 3.91% | ₹ 21.94 Cr. |
| Speciality retail | 3.74% | ₹ 20.96 Cr. |
| Consumer products | 2.19% | ₹ 12.28 Cr. |
| Others | .37% | - |
Top Stock Holdings of Aditya Birla Sun Life Pharma & Healthcare Fund
| Name of Stocks | Holding Percentage | Holding Values in Crore |
|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 13.44% | ₹ 75.48 Cr. |
| Dr. Reddys Laboratories Ltd. | 9.92% | ₹ 55.69 Cr. |
| Cipla Ltd. | 9.55% | ₹ 53.66 Cr. |
| Divis Laboratories Ltd. | 7.73% | ₹ 43.40 Cr. |
| Torrent Pharmaceuticals Ltd. | 5.32% | ₹ 29.88 Cr. |
| Others | 54.04% | - |
Other Holdings
| Holding Type | Holding Percentage |
|---|---|
| TREPS | 1.60% |
| Net Receivables | -0.34% |